Literature DB >> 16373831

Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice.

Scott M Golembeski1, James West, Yuji Tada, Karen A Fagan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16373831     DOI： 10.1378/chest.128.6_suppl.572S-a

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  35 in total

1.  Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats.

Authors:  Erquan Zhang; Junko Maruyama; Ayumu Yokochi; Yoshihide Mitani; Hirofumi Sawada; Masakatsu Nishikawa; Ning Ma; Kazuo Maruyama
Journal:  J Anesth       Date:  2015-05-01       Impact factor: 2.078

2.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Inflammation in Pulmonary Arterial Hypertension.

Authors:  Timothy Klouda; Ke Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension.

Authors:  Soni Savai Pullamsetti; Werner Seeger; Rajkumar Savai
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

5.  Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.

Authors:  Yuichi Tamura; Carole Phan; Ly Tu; Morane Le Hiress; Raphaël Thuillet; Etienne-Marie Jutant; Elie Fadel; Laurent Savale; Alice Huertas; Marc Humbert; Christophe Guignabert
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

6.  Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Authors:  Todd M Bull; Christina A Meadows; Christopher D Coldren; Mark Moore; Sylk M Sotto-Santiago; Serge P Nana-Sinkam; Thomas B Campbell; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

7.  Interleukin-6 overexpression induces pulmonary hypertension.

Authors:  M Kathryn Steiner; Olga L Syrkina; Narasaish Kolliputi; Eugene J Mark; Charles A Hales; Aaron B Waxman
Journal:  Circ Res       Date:  2008-12-12       Impact factor: 17.367

8.  Exercise-induced pulmonary arterial hypertension.

Authors:  James J Tolle; Aaron B Waxman; Teresa L Van Horn; Paul P Pappagianopoulos; David M Systrom
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

9.  Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension.

Authors:  Yoshiaki Furuya; Toru Satoh; Masataka Kuwana
Journal:  Int J Rheumatol       Date:  2010-08-02

10.  The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice.

Authors:  Lakshmi Kugathasan; Julie Basu Ray; Yupu Deng; Effat Rezaei; Daniel J Dumont; Duncan J Stewart
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.